批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1997/02/21 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
PRIORITY
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2024/12/19 |
SUPPL-43(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2024/10/25 |
SUPPL-44(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2024/03/18 |
SUPPL-42(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2024/02/05 |
SUPPL-40(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/10/19 |
SUPPL-39(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/12/05 |
SUPPL-38(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/03/08 |
SUPPL-37(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/10/07 |
SUPPL-36(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. |
| 2017/03/17 |
SUPPL-35(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2015/04/16 |
SUPPL-33(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2014/06/09 |
SUPPL-32(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2013/06/06 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2012/03/26 |
SUPPL-28(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2012/03/26 |
SUPPL-27(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2011/04/15 |
SUPPL-26(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2011/01/04 |
SUPPL-25(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
| 2010/07/29 |
SUPPL-24(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2009/03/05 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2009/03/05 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2009/03/05 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2009/03/05 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2003/09/24 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/10/10 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 2002/09/11 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/07/17 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2001/05/09 |
SUPPL-5(补充) |
Approval |
Efficacy-New Indication |
STANDARD
|
|
|
| 2001/05/09 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2001/04/25 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 1998/07/27 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC)-Packaging |
PRIORITY
|
|
|
| 1998/07/27 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
| 1998/02/20 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC)-Control |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 001 |
5707975 |
2015/01/13 |
|
|
|
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
| 6407079 |
2019/06/18 |
|
|
|
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
与本品治疗等效的药品
>>>活性成分:ITRACONAZOLE; 剂型/给药途径:SOLUTION;ORAL; 规格:10MG/ML; 治疗等效代码:AA<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 020657 |
001 |
NDA |
SPORANOX |
ITRACONAZOLE |
SOLUTION;ORAL |
10MG/ML |
Discontinued |
Yes |
No |
AA |
1997/02/21
|
JANSSEN PHARMS |
| 205573 |
001 |
ANDA |
ITRACONAZOLE |
ITRACONAZOLE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
Yes |
AA |
2015/10/30
|
AMNEAL PHARMS |
| 212239 |
001 |
ANDA |
ITRACONAZOLE |
ITRACONAZOLE |
SOLUTION;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2020/09/01
|
ANNORA PHARMA |